drugset / Trial / NCT01812239

Vaginal Progesterone in Twins With Short Cervix

NCT01812239

Phase 2/3 Withdrawn Obstetrix Medical Group
RandomizedParallel-groupTriple-blindTreatment

Summary

A Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial of Vaginal Progesterone to Prevent Early Preterm Birth In Twin Pregnancy with Short Cervix.

Timeline

Start
2014-03
Primary completion
2017-08
Completion
2018-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Progesterone Other / unclassified 200 mg Other

Indications

No indication recorded.